Journal article

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines

Delphine Merino, Gemma L Kelly, Guillaume Lessene, Andrew H Wei, Andrew W Roberts, Andreas Strasser

Cancer Cell | CELL PRESS | Published : 2018

Grants

Awarded by National Health and Medical Research Council (NHMRC), Australia


Awarded by NHMRC


Awarded by Cancer Council Victoria


Awarded by VCA


Awarded by Leukemia & Lymphoma Society Special Center of Research


Awarded by Medical Research Future Fund


Funding Acknowledgements

We thank Peter Maltezos for assistance with preparation of the figures, Catherine McLean with editing of the manuscript, and our colleagues for insightful discussions. We apologize to authors whose contributions have not been cited due to space limitations. D.M. was supported by the National Health and Medical Research Council (NHMRC), Australia (NHMRC 1101378). G.L.K. was supported by project grants from the NHMRC (1086291), Cancer Council Victoria (1086157 and 1147328) and the Leukemia Foundation Australia, and a fellowship from the VCA (MCRF 17028). A.S. was supported by the NHMRC (1116937, 1113133, and 1143105), the Cancer Council Victoria (1102104) and a Leukemia & Lymphoma Society Special Center of Research (7015-18). Bequests from the Estate of Anthony Redstone and the Craig Perkins Cancer Research Foundation were provided to A.S. and G.L.K. A.W. was supported by a fellowship from the Medical Research Future Fund (1141460) and grants from the NHMRC (1126843), VCA, and Australian Cancer Research Foundation. G.L. was supported by NHMRC project program grant (1113133) and fellowship (1117089).